RKCLF yields 6024.10% · PFE yields 6.13%● Live data
📍 RKCLF pulled ahead of the other in Year 1
Combined, RKCLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RKCLF + PFE for your $10,000?
Rockcliff Metals Corporation operates as a resource development and exploration company and near-term copper-zinc producer in Canada. It holds interests in various advance stage, copper, and zinc dominant volcanogenic massive sulphide deposits in the Snow Lake area of Manitoba. It holds a 100% interest in Tower property located in the Thompson Nickel Belt District in Manitoba; a 100% interest in the Rail; the Freebeth property; the Morgan property; and the Copperman property located in the Snow Lake District in Manitoba. The company is a principal landholder in the Flin Flon-Snow Lake greenstone belt, which is home to the Paleoproterozoic VMS district, hosting mines and deposits containing copper, zinc, gold, and silver. It holds an extensive portfolio of properties that totals approximately 4,000 square kilometers and include several undeveloped VMS deposits. The company was formerly known as Rockcliff Copper Corporation and changed its name to Rockcliff Metals Corporation in November 2017. Rockcliff Metals Corporation was founded in 2005 and is headquartered in Toronto, Canada.
Full RKCLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.